`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`
`
`MAKO SURGICAL CORP.,
`Petitioner
`
`v.
`
`BLUE BELT TECHNOLOGIES, INC.,
`Patent Owner
`
`______________________
`
`Case IPR2015-00630
`Patent No. 6,205,411 B1
`_______________________
`
`
`PETITIONER MAKO SURGICAL CORP.’S OPPOSITION
`TO PATENT OWNER’S CONTINGENT MOTION TO AMEND
`
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`dc-819447
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`TABLE OF CONTENTS
`
`I.
`II.
`III.
`
`INTRODUCTION ........................................................................................... 1
`DIGIOIA IS AT LEAST § 102(A) PRIOR ART ............................................ 2
`PATENT OWNER DOES NOT ESTABLISH THAT THE PROPOSED
`SUBSTITUTE CLAIMS WOULD HAVE BEEN PATENTABLE OVER
`OTHER PRIOR ART OF RECORD ............................................................... 9
`A.
`Patent Owner Failed to Distinguish Material Art of Record .............. 10
`B.
`DiGioia II Alone, or in Combination with Chao and O’Toole,
`Invalidates Patent Owner’s Proposed New Claims ............................. 11
`1. DiGioia II, Chao, and O’Toole References ......................................... 11
`2.
`Pre-operative kinematic biomechanical simulator . . . executing on the
`computer system .......................................................................................... 13
`3.
`Simulate movement of the hip joint with the artificial
`component/implant in a test position ........................................................... 14
`4. Calculate a range of motion based on the simulated movement and
`determine an implant position ...................................................................... 16
`5. Taylor Reference ................................................................................. 17
`C.
`Claim Chart for Patent Owner’s Proposed New Claims ..................... 18
`IV. Conclusion ..................................................................................................... 24
`
`
`dc-819447
`
`ii
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`
`
`
`CASES
`
`Table of Authorities
`
`Page(s)
`
`Amgen Inc. v. Hoechst Marion Roussel, Inc.,
`314 F.3d 1313 (Fed. Cir. 2003) .......................................................................................16
`
`Geo M. Martin Co. v. All. Mach. Sys. Int’l LLC,
`618 F.3d 1294 (Fed. Cir. 2010) .......................................................................................15
`
`Idle Free Systems, Inc. v. Bergstrom, Inc.,
`Case IPR2012-00027, 2013 WL 5947697 (PTAB June 11, 2013) .................... 10
`
`In re Katz,
`687 F.2d 450 (C.C.P.A. 1982) .......................................................................................2, 3
`
`MasterImage3D, Inc. v. Reald Inc.,
`Case IPR2015-00040, 2015 WL 4383224 (PTAB July 15, 2015) .........................10
`
`Nike, Inc. v. Adidas AG,
`No. 2014-1719, 2016 WL 537609 (Fed. Cir. Feb. 11, 2016) ..............................9, 10
`
`Toyota Motor Corp. v. Am. Vehicular Scis. LLC,
`Case IPR2013-00422, slip op. (PTAB Mar. 7, 2014) ..................................................9
`
`OTHER AUTHORITIES
`
`M.P.E.P. § 2132.01(I) ................................................................................................................2
`
`dc-819447
`
`iii
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`PETITIONER’S EXHIBIT LIST
`
`Exhibit Description
`
`Exhibit #
`
`U.S. Patent No. 6,205,411 (“the ’411 patent”)
`
`Prosecution History of U.S. Patent No. 6,205,411
`
`Prosecution History of U.S. Patent No. 5,880,976
`
`Declaration of Robert D. Howe
`
`A.M. DiGioia et al., “HipNav: Pre-operative Planning and
`Intraoperative Navigational Guidance for Acetabular Implant
`Placement in Total Hip Replacement Surgery,” 2nd CAOS
`Symposium, 1996 (“DiGioia”)
`
`Anthony M. DiGioia III et al., “An Integrated Approach to
`Medical Robotics and Computer Assisted Surgery in
`Orthopaedics,” Proc. 1st Int’l Symposium on Medical Robotics and
`Computer Assisted Surgery, pp. 106-111, 1995 (“DiGioia II”)
`
`E.Y.S. Chao et al., “Simulation and Animation of Musculoskeletal
`Joint System,” Transactactions of the ASME, Vol. 115, pp. 562-
`568, Nov. 1993 (“Chao”)
`
`R.V. O’Toole III et al., “Towards More Capable and Less Invasive
`Robotic Surgery in Orthopaedics,” Computer Vision, Virtual
`Reality and Robotics in Medicine Lecture Notes in Computer
`Science, Vol. 905, pp. 123-130, 1995 (“O’Toole”)
`
`Russell H. Taylor et al., An Image-Directed Robotic System for
`Precise Orthopaedic Surgery, IEEE Transactions on Robotics and
`Automation, Vol. 10, No. 3, June 1994 (“Taylor”)
`
`Deposition Transcript of Dr. Cleary
`
`Deposition Transcript of Dr. Jaramaz – Filed Under Seal
`
`Deposition Transcript of Dr. Jaramaz – Redacted
`
`Declaration of Eric R. Kischell
`
`dc-819447
`
`iv
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`Exhibit Description
`
`Exhibit #
`
`Intentionally left blank
`
`Intentionally left blank
`
`U.S. Patent No. 5,880,976 (“the ’976 patent”)
`
`Intentionally left blank
`
`Web page from Carnegie Mellon University for Branislav Jaramaz
`
`A.M. DiGioia et al., “HipNav: Pre-operative Planning and Intra-
`Operative Navigational Guidance for Acetabular Implant
`Placement in Total Hip Replacement Surgery,” Proc. of the CAOS
`Symposium, Nov. 1995.
`
`CAOS Symposium Final Program, 18 November 30 - December 2,
`1995
`
`D.A. Simon et al., “Development and Validation of a Navigational
`Guidance System for Acetabular Implant Placement”
`
`1014
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`dc-819447
`
`v
`
`REDACTED VERSION
`
`
`
`
`
`I.
`
`INTRODUCTION
`
`Patent Owner Blue Belt Technologies attempts to avoid invalidity by filing a
`
`
`
`contingent motion to amend. The premise of the motion is that if the claims are
`
`amended as proposed in new claims 18-34, the specification filed on February 21,
`
`1997 would then support the claims such that the primary DiGioia reference would
`
`no longer serve as § 102(b) prior art. However, even if the Patent Owner may
`
`reach back to the earlier priority date of February 21, 1997 by limiting the claims
`
`to the hip joint, the DiGioia article remains § 102(a) prior art because the article
`
`has a different inventive entity than the ‘411 patent. There are two authors who
`
`contributed to the conception of the system in the article that are not listed as
`
`inventors on the patent. There is also one inventor on the ‘411 patent who is not
`
`listed as an author of the article. Patent Owner offers the Jaramaz Declaration in
`
`an attempt to get around this inventorship problem, but his testimony lacks
`
`foundation regarding the inventive entity involved with the article. Indeed, while
`
`Patent Owner failed to submit a declaration from anyone who had actual
`
`knowledge about the naming of the authors who contributed to DiGioia, Petitioner
`
`has submitted a declaration from Mr. Eric Kischell, one of the authors who was not
`
`named on the ’411 patent, explaining his role in drafting the article and developing
`
`the system described therein. Because he clearly belongs to the inventive entity of
`
`dc-819447
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`the DiGioia article, the inventive entity of DiGioia is not the same as that of the
`
`’411 patent, such that DiGioia is at least § 102(a) prior art.
`
`Moreover, as argued in the Petition, an earlier 1995 reference, DiGioia II, in
`
`combination with the Chao, O’Toole, and Taylor references invalidates the issued
`
`claims. These same combinations also invalidate the new claims 18-34. The
`
`amended claims’ focus on the hip joint does not solve anything for Patent Owner
`
`because these prior art references were explicitly focused on the hip joint. Patent
`
`Owner not only failed to distinguish the proposed new claims from these prior art
`
`references, but failed to even address certain prior art of record, as was required.
`
`II. DIGIOIA IS AT LEAST § 102(A) PRIOR ART
`
`Even if Patent Owner is permitted to amend the ’411 patent to substitute
`
`proposed claims 18-34 for claims 1-17, DiGioia still qualifies as prior art against
`
`the proposed substitute claims. When a printed publication is filed that describes
`
`the subject matter of the claimed invention and is published before an application,
`
`the article may raise a substantial question whether the applicant is the inventor. In
`
`re Katz, 687 F.2d 450, 455 (C.C.P.A. 1982); see also M.P.E.P. § 2132.01(I) (“[a]
`
`prima facie case is made out under pre-AIA 35 U.S.C. 102(a) if, within 1 year of
`
`the filing date, the invention, or an obvious variant thereof, is described in a
`
`‘printed publication’ whose authorship differs in any way from the inventive entity
`
`dc-819447
`
`2
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`unless it is stated within the publication itself that the publication is describing the
`
`applicant’s work”).
`
`A prima facie case that DiGioia is prior art has been made out under §
`
`102(a) because DiGioia was published no later than 1996 and the authorship of
`
`DiGioia differs from that of the ’411 patent: Dr. Takeo Kanade, who is listed as an
`
`inventor of the ’411 patent, is not listed as an author of DiGioia; and DiGioia lists
`
`Mr. Bruce Colgan and Mr. Eric Kischell as authors, neither of whom are listed as
`
`inventors of the ’411 patent. (Ex. 1005 at 1; Ex. 1001 at 1.)
`
`Because of the different authors of DiGioia, it was incumbent on Patent
`
`Owner to provide a showing which would lead to a reasonable conclusion that the
`
`inventive entity of DiGioia and the ’411 patent are identical. In re Katz, 687 F.2d
`
`at 455. Patent Owner has failed to do so. Patent Owner has submitted only one
`
`declaration on the subject, that of Dr. Jaramaz, the founder and CTO of Blue Belt.
`
`At his deposition, it became clear that he did not have the factual knowledge
`
`necessary to establish that the inventive entities were identical. Indeed, Dr.
`
`Jaramaz appears to have signed a declaration without having actual recollections to
`
`support what was written.
`
`Dr. Jaramaz states in his declaration that Dr. Kanade, an inventor of the ’411
`
`patent, was not listed as an author of the DiGioia article because he was not
`
`working day-to-day on the system at the time. (Ex. 2002 at ¶ 11.) Dr. Jaramaz
`
`dc-819447
`
`3
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`named Dr. Kanade to other articles at the time, but not this one. (Ex. 1012 at
`
`23:16-25:13.) Although Dr. Jaramaz’s declaration contains extensive comments
`
`on the contributions to the article, he did not know who decided to omit Dr.
`
`Kanade as an author of the article, and did not ask anyone else how this process
`
`occurred:
`
`Q Do you know who decided to not list Dr. Kanade on the
`HipNav article? Do you know who made that decision?
`A No.
`Q Was it you?
`A No. It wasn’t me.
`Q You haven’t spoken with anyone who made the decision to
`determine why they did it, have you?
`A Not that I recall. No.
`Q If you didn’t make the decision yourself and you haven’t
`spoken to anyone who did make the decision and you are not sure
`who made the decision, you can’t really tell us why he was left off.
`Correct?
`
`. . .
`A I can tell you my opinion, if that is worth anything. I cannot tell you the
`
`exact reasons.
`
`(Ex. 1012 at 25:14-26:5 (objection omitted).) Thus, at the end of the day, Patent
`
`Owner has not offered any factual testimony explaining Dr. Kanade’s omission
`
`from the article. Without such testimony, his omission from the inventive entity of
`
`dc-819447
`
`4
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`DiGioia means that there is a different inventive entity pertaining to the system
`
`described in the article than the one in the ’411 patent, and DiGioia qualifies as §
`
`102(a) prior art.
`
`There are further problems with Patent Owner’s “same inventive entity”
`
`argument. Mr. Kischell is listed as a co-author of DiGioia, but is not listed as an
`
`inventor of the ’411 patent. Because he is part of the inventive entity of the system
`
`included in DiGioia, there is an additional hurdle that Patent Owner has not
`
`overcome. In Dr. Jaramaz’s declaration, he admitted that Mr. Kischell was
`
`involved in developing the HipNav System discussed in DiGioia on a day-to-day
`
`basis, and that Mr. Kischell developed a user interface for the HipNav system.
`
`(Ex. 2002 at ¶¶ 11, 16.) In his deposition, Dr. Jaramaz further admitted that the
`
`software that Mr. Kischell developed made it possible to convert the data from CT
`
`scans into 3D geometric models in the HipNav system. (Ex. 1012 at 26:6-29:18.)
`
`This software was not commercially available and needed to be created specifically
`
`for the HipNav system. (Id. at 27:14-18.) All of these admissions point to Mr.
`
`Kischell being part of the inventive entity of the DiGioia article.
`
`Although Dr. Jaramaz’s declaration attempts to minimize Mr. Kischell’s
`
`contribution to the system and the article, in his deposition, it became clear that he
`
`did not know what Mr. Kischell’s contribution had been to the article. (Ex. 1012 at
`
`47:9-19.) Mr. Kischell did not report to Dr. Jaramaz. (Id. at 29:5-11.) Thus, once
`
`dc-819447
`
`5
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`again, in describing Mr. Kischell’s role in the article, Dr. Jaramaz was simply
`
`providing his opinion about what might have happened, rather than what did in fact
`
`happen.
`
`Fortunately, we do not need to speculate about Mr. Kischell’s contribution
`
`as he has provided a declaration on the subject. (See Ex. 1013.) At the time of his
`
`work on the article, Mr. Kischell held a M.S. in Electrical Engineering from Texas
`
`A&M University, and a B.S. in Electrical Engineering from Northeastern
`
`University. (Ex. 1013 at ¶ 1.) His expertise encompasses image processing,
`
`pattern recognition, 3D visualization, object oriented architecture, user interface
`
`prototyping and code optimization. (Id.) In working on the HipNav system, he
`
`solved the problem of how to integrate the intra-operative tracking and guidance
`
`system into a graphical user interface. (Id.at ¶¶ 7-8.) The data had to be integrated
`
`and tracked in real time in a capable graphical user interface so that the surgeon
`
`could utilize the intra-operative tracking and guidance system to accurately place
`
`the implant in the predetermined optimal position. (Id.at ¶ 8.) He also developed a
`
`way to process the CT scans so that they could be utilized in the pre-operative
`
`planner. (Id.at ¶ 9.) Both of these solutions were utilized in the HipNav System as
`
`represented in the DiGioia article. (Id.at ¶¶ 7-9.) It took approximately 14 months
`
`to create the graphical user interface, and approximately 20 months to develop the
`
`CT scan pre-processing software. (Id.at ¶ 10.) Mr. Kischell reviewed and edited
`
`dc-819447
`
`6
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`the DiGioia article before its publication. (Id.at ¶ 11.) Mr. Kischell’s contributions
`
`to solving the software problems in the HipNav system were important to the
`
`project’s success and in any event were not insubstantial. (Id.at ¶ 11.) Because
`
`Mr. Kischell was properly a part of the inventive entity in DiGioia and was not an
`
`inventor of the ’411 patent, Patent Owner’s “same inventive entity” argument fails.
`
`Beyond these problems with his statements on the authors of DiGioia, Dr.
`
`Jaramaz made further factual statements in his declaration that, at a minimum,
`
`lacked foundation. While stating in his declaration that “[o]n February 22, 1996,
`
`we created an initial version of [DiGioia]”, his own publication list dates the article
`
`as having been published in 1995. (Ex. 1012 at 17:6-18:7; Ex. 1018 at 8.) He also
`
`cites DiGioia as having been published in 1995 in one of his earlier articles and the
`
`“pdf” of the article on his website states that it was published in 1995. (Ex. 1012 at
`
`20:24-21:20; (A.M. DiGioia et al., “HipNav: Pre-operative Planning and Intra-
`
`Operative Navigational Guidance for Acetabular Implant Placement in Total Hip
`
`Replacement Surgery,” Proc. of the CAOS Symposium, Nov. 1995 ( Ex. 1019 at
`
`1); D.A. Simon et al., “Development and Validation of a Navigational Guidance
`
`System for Acetabular Implant Placement” (Ex. 1021 at 10.) On cross
`
`examination, he agreed that the article was first published in 1995 and that his
`
`dating of the article as being created on February 22, 1996 was incorrect. (Ex.
`
`1012 at 21:21-22:11.) However, after meeting with his counsel during a break, he
`
`dc-819447
`
`7
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`testified on redirect that in fact the article had been published in 1996, blaming the
`
`1995 dates in his materials on his secretary. (Ex. 1012 at 59:2-64:25.) Although
`
`the testimony is unclear, it is very apparent that Dr. Jaramaz does not know or
`
`recall when the first version of the article had been drafted or published. He
`
`simply signed the declaration that had been drafted for him saying that DiGioia had
`
`been written on February 22, 1996, conveniently exactly one year before the filing
`
`date, without actually knowing when the article had actually been drafted.
`
`Dr. Jaramaz’s willingness to help the Patent Owner’s cause may be the
`
`product of bias. He recently received
`
` due to the sale of Blue
`
`Belt to Smith & Nephew for $275 million. (Ex. 1012 at 4:9-6:11.) There is also a
`
`holdback amount of around
`
` percent of the $275 million in escrow that will be
`
`paid out -- or not paid out -- based on subsequent events. (Ex. 1012 at 6:12-6:16.)
`
`When asked whether success or failure in this proceeding could affect the amount
`
`of the payment of the
`
` of funds in escrow, he testified that he
`
`did not know. (Ex. 1012 at 6:17-7:10.) It is not credible that the head of
`
`technology in a company with only a few patents would not know whether a patent
`
`matter involving two of those patents could impact a
`
` escrow account
`
`or not. It appears more likely than not that it does, and if Patent Owner maintains
`
`to the contrary, the terms of that escrow should be produced.
`
`dc-819447
`
`8
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`Given the weaknesses of Dr. Jaramaz’s declaration, the fact that no
`
`disclaiming affidavits were filed by any of the other DiGioia co-authors, and the
`
`testimony in the Kischell declaration on his role in the article, the Court must
`
`conclude that Patent Owner has failed to meet its burden of demonstrating that
`
`DiGioia has the same inventive entity. Thus, DiGioia remains prior art under §
`
`102(a). Because DiGioia focuses on the hip joint, the amended claims 18-34 are
`
`invalid for obviousness in the same way that DiGioia renders claims 1-17 obvious.
`
`See Petition Owner Mako Surgical’s Reply to Patent Owner’s Response at 17-25.
`
`In addition, the other minor changes made to the new claims were already present
`
`in original claim 17, and are therefore invalid for obviousness in the same way that
`
`DiGioia rendered claim 17 obvious. Id.
`
`III. PATENT OWNER DOES NOT ESTABLISH THAT THE PROPOSED
`SUBSTITUTE CLAIMS WOULD HAVE BEEN PATENTABLE
`OVER OTHER PRIOR ART OF RECORD
`
`“[T]he burden of establishing the patentability of proposed substitute claims
`
`[is] on the patent owner[.]” Nike, Inc. v. Adidas AG, No. 2014-1719, 2016 WL
`
`537609, at *5 (Fed. Cir. Feb. 11, 2016); see also Toyota Motor Corp. v. Am.
`
`Vehicular Scis. LLC, Case IPR2013-00422, slip op. at 4 (PTAB Mar. 7, 2014)
`
`(Paper 25) (noting that a patent owner “bears the burden of proof to establish that it
`
`is entitled to the relief requested in the motion to amend”) (citing 37 C.F.R. §
`
`42.20(c)). Further, “a motion to amend will be successful only if the patent owner
`
`dc-819447
`
`9
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`‘persuade[s] the Board that the proposed substitute claim is patentable over the
`
`prior art of record, and over prior art not of record but known to the patent
`
`owner.’” Nike, Inc., 2016 WL 537609, at *19 (citing Idle Free Systems, Inc. v.
`
`Bergstrom, Inc., Case IPR2012-00027, 2013 WL 5947697 at*4 (PTAB June 11,
`
`2013) (Paper 26) (emphasis omitted)). Patent Owner has not only failed to address
`
`prior art of record, but has also failed to show a patentable distinction over prior art
`
`that was outlined in the Petition.
`
`A.
`
`Patent Owner Failed to Distinguish Material Art of Record
`
`As mentioned above, Patent Owner must show patentable distinction over
`
`the prior art of record. Id. “Prior art of record” includes “a. any material art in the
`
`prosecution history of the patent; b. any material art of record in the current
`
`proceeding, including art asserted in grounds on which the Board did not
`
`institute review; and c. any material art of record in any other proceeding before
`
`the Office involving the patent.” MasterImage3D, Inc. v. Reald Inc., Case
`
`IPR2015-00040, 2015 WL 4383224, at 2 (PTAB July 15, 2015) (Paper 42)
`
`(emphasis added). In its Motion, Patent Owner discussed only the DiGioia II
`
`(Ex.1006) and Taylor (Ex. 1009) references, noting that they were the “most
`
`relevant” prior art references cited by Petitioner. (Motion to Amend at 14.) But
`
`Patent Owner failed to even address the Chao (Ex. 1007) and O’Toole (Ex. 1008)
`
`dc-819447
`
`10
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`references, which Petitioner also included in the Petition. Thus, Patent Owner has
`
`not met its burden to show patentable distinction over the prior art of record.
`
`B. DiGioia II Alone, or in Combination with Chao and O’Toole,
`Invalidates Patent Owner’s Proposed New Claims
`
`Patent Owner unconvincingly argues that the new limitations added to
`
`proposed new claims 18, 27, and 34 are not taught by or obvious in light of
`
`DiGioia II and Taylor references. (Motion at 15-16.) But as explained below,
`
`DiGioia II, either alone or in combination with Chao and O’Toole, teaches these
`
`added limitations. Patent Owner failed to address the Chao and O’Toole
`
`references in its Motion.
`
`DiGioia II, Chao, and O’Toole References
`
`1.
`
`DiGioia II is an article published at least as early as 1995, 1-2 years prior to
`
`the February 21, 1997 date to which the ’411 patent claims priority. (Ex. 1006;
`
`http://www.ri.cmu.edu/person.html?type=publications&person_id=65 (listing
`
`publication date as 1995).) Thus, DiGioia II qualifies as prior art under § 102(b).
`
`DiGioia II describes systems and methods to improve accuracy of joint
`
`replacements through the use of pre-operative planning and computer systems.
`
`DiGioia II proposes a pre-operative planning component and the use of a simulator
`
`to determine optimal implant positioning. It describes that if biomechanics-based
`
`preoperative planning is linked with patient and pre-determined implant data, as
`
`well as a computer or robot monitoring and assisting the surgery, surgical results
`
`dc-819447
`
`11
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`could be improved. A main figure in the article, Figure 1, displays the combined
`
`system, indicating with arrows communication between the various components.
`
`Like the ’411 patent, DiGioia II discloses an approach to improved surgical
`
`techniques incorporating pre-operative planning with biomechanical analysis and
`
`computer or robot-assisted surgery. (Ex. 1006 at 108.)
`
`The O’Toole reference is another article written by several of the same
`
`authors that wrote DiGioia II. (Ex. 1004 ¶ 49.) O’Toole is also § 102(b) prior art
`
`to the ’411 patent, even with the proposed new claims, as O’Toole was published
`
`in 1995. (Id.) A person of ordinary skill would be motivated to combine DiGioia
`
`II with O’Toole, as O’Toole also describes a system for planning a hip surgery
`
`involving a femoral implant and a femur and shares most of its authors with
`
`DiGioia II (including respective lead authors O’Toole and DiGioia along with four
`
`other authors). (Id.¶ 33.)
`
`The Chao reference is an article published in November of 1993. (Ex. 1007
`
`at 1.) Chao was published in 1993, and is therefore also § 102(b) prior art to the
`
`’411 patent even with the proposed new claims. A person of ordinary skill in the
`
`art would be motivated to combine DiGioia II with Chao, because Chao addressed
`
`the same subject matter as DiGioia II. (Ex. 1004 ¶ 32.) Like DiGioia II, Chao
`
`addresses simulation and animation of joints. Also like DiGioia II, Chao expresses
`
`dc-819447
`
`12
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`a desire to allow a user to simulate joint pressure distribution in order to improve
`
`joint replacement, including hip replacements.
`
`2.
`
`Pre-operative kinematic biomechanical simulator . . .
`executing on the computer system
`
`New claims 18 and 27 include the following limitation: “a pre-operative
`
`kinematic biomechanical simulator . . . executing on the computer system to:[.]”
`
`DiGioia II discloses this limitation. DiGioia II describes the use of a pre-operative
`
`biomechanical analysis system: “Biomechanical analyses would provide the
`
`surgeon with feedback concerning the distribution of strain in the bone, and the
`
`amount of bone-implant contact for a given surgical plan.” (Ex. 1006 at 107.)
`
`“Biomechanical analyses should consider . . . bone remodeling effects due to joint
`
`loading and varying load transfer mechanisms.” (Id.) This biomechanical
`
`analysis system relates to movement and is therefore a kinematic biomechanical
`
`simulator. Additionally, DiGioia II Figure 1 depicts a pre-operative biomechanical
`
`analysis system on a computer system. (Ex. 1006 at Fig. 1 (“Biomechanic-based
`
`Preoperative Planning”; “3-D Templating”; “Biomechanical Analysis”).) In
`
`addition, this limitation is made obvious by DiGioia II in view of Chao. Chao
`
`discusses computer-based software for three-dimensional geometric data base of
`
`the human musculoskletal system, and discloses biomechanical simulations used in
`
`preoperative planning and for selection and planning for total joint replacement.
`
`(Ex. 1007 at 2, 4-6.)
`
`dc-819447
`
`13
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`3.
`
`Simulate movement of the hip joint with the artificial
`component/implant in a test position
`
`New claims 18 and 27 include the following limitation: “simulate
`
`movement of the hip joint with the artificial component in a test position using the
`
`geometric model of the hip joint and the component model;” and new claim 34
`
`includes the following limitation: “simulating movement of the joint with the
`
`artificial implant in a test position[.]” DiGioia II discloses these limitations.
`
`By “provid[ing] the surgeon with feedback concerning the distribution of
`
`strain in the bone,” “the amount of bone-implant contact for a given surgical
`
`plan[,]” and by recommending that the biomechanical analyses “consider . . . bone
`
`remodeling effects due to joint loading and varying load transfer mechanisms[,]”
`
`DiGioia II’s biomechanical system is simulating movement of the hip joint with
`
`the artificial component/implant in a test position. DiGioia II discloses that
`
`software utilizes imaging data to generate 3-D skeleton models. (Ex. 1006 at Fig.
`
`1 (“Imaging”; “3-D Skeleton Model”).) These 3-D skeleton models are geometric
`
`models of the hip joint. DiGioia II teaches a three-dimensional component model
`
`by in Figure 1 by depicting a computer and an “Implant Database” as part of
`
`“Patient Data,” which are connected to 3-D Templating on a computer system in
`
`the “Biomechanics-based Preoperative Planning” section. DiGioia Figure 2 also
`
`depicts a 3-D skeleton or “bony” model and an implant model. (Ex. 1006 at Fig.
`
`2.) It is clear that the biomechanical analysis system utilizes both the 3-D skeleton
`
`dc-819447
`
`14
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`model and the Implant Database with the 3-D Templating by the arrows going
`
`from Patient Data to Biomechanical-based Preoperative Planning sections of
`
`Figure 1, and additionally by the arrow going from 3-D Templating to
`
`Biomechanical Analysis.
`
`Patent Owner argues that the statement in DiGioia II that the researchers
`
`were “working toward developing of an automatized procedure that will include
`
`biomechanical simulation as a component of a preoperative surgical planner”
`
`somehow means that this limitation is not disclosed by DiGioia. (Motion at 16.)
`
`But just because a fully automated preoperative surgical planning procedure that
`
`included a biomechanical simulation component was not yet entirely developed
`
`does not mean that DiGioia II did not disclose this limitation. DiGioia II Figure 1
`
`clearly shows the biomechanical analysis system integrated into preoperative
`
`planning. Further development to make the system more autonomous is not
`
`necessary to satisfy this limitation. See Geo M. Martin Co. v. All. Mach. Sys. Int’l
`
`LLC, 618 F.3d 1294, 1302 (Fed. Cir. 2010) (“Under an obviousness analysis, a
`
`reference need not work to qualify as prior art. . . . Even if a reference discloses an
`
`inoperative device, it is prior art for all that it teaches”) (internal quotations and
`
`citations omitted); Amgen Inc. v. Hoechst Marion Roussel, Inc., 314 F.3d 1313,
`
`1357 (Fed. Cir. 2003) (“Under § 103, however, a reference need not be enabled; it
`
`qualifies as a prior art, regardless, for whatever is disclosed therein”), aff’d in part
`
`dc-819447
`
`15
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`and rev’d in part, on other grounds, 457 F.3d 1293 (Fed. Cir. 2006). Thus, this
`
`limitation was disclosed or made obvious in light of DiGioia II.
`
`4.
`
`Calculate a range of motion based on the simulated
`movement and determine an implant position
`
`New claims 18 and 27 include the following limitation: “calculate a range
`
`of motion of the artificial component and the hip joint for the test position based on
`
`the simulated movement;” and new claim 34 includes the following limitation:
`
`“calculating a range of motion of the artificial implant and the bones comprising
`
`the joint for the test position based on the simulated movement[.]” Additionally,
`
`New claims 18 and 27 include the following limitation: “determine a position for
`
`implantation for the artificial component based at least in part on the calculated
`
`range of motion[,]” and new claim 34 includes the following limitation:
`
`“determining an implant position based on a predetermined range of motion and
`
`the calculated range of motion.” Patent Owner argues that DiGioia II’s reference
`
`to “biomechanical simulation” does not teach or suggest these limitations. But
`
`Patent Owner failed to even acknowledge or address the Chao reference. DiGioia
`
`II in view of Chao renders these limitations obvious.
`
`Chao specifically addresses simulation and animation of joints. (Ex. 1007.)
`
`Chao indicates that its simulations may be used for “[s]election and planning in
`
`total joint replacement” and discloses examples where “[j]oint pressure and motion
`
`were obtained through model simulation.” (Ex. 1007 at 5.) In light of Chao, it
`
`dc-819447
`
`16
`
`REDACTED VERSION
`
`
`
`Petitioner’s Opp. to Patent Owner’s Contingent Motion to Amend IPR2015-00630
`
`
`would have been obvious to simulate motion of the hip joint/bones comprising the
`
`joint with the implant in place and therefore calculate the range of motion of the